Unknown

Dataset Information

0

The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.


ABSTRACT: The clinicopathological significance of altered SWI/SNF complex has not been well evaluated in gastric cancer (GC). We examined SMARCA2, SMARCA4, SMARCB1 and ARID1A expression by immunohistochemistry in 1224 surgically resected GCs with subtyping into Epstein-Barr virus (EBV), microsatellite instability (MSI) and non-EBV/MSI Lauren histotypes. SWI/SNF mutations were investigated using the GC dataset of the TCGA Pan-Cancer Atlas. Clinicopathological association was assessed by statistical analysis. There were 427 cases (35%) of SWI/SNF-attenuated GC, including 344 SMARCA2 (28%), 28 SMARCA4 (2%), 11 SMARCB1 (1%) and 197 ARID1A (16%) cases. Simultaneous alterations of multiple subunits were observed. Compared to SWI/SNF-retained cases, SWI/SNF-attenuated GC exhibited a significant predilection to older ages, EBV and MSI genotypes, higher lymphatic invasion and less hematogenous recurrence (P < 0.05). SWI/SNF attenuation was an independent risk factor for short overall survival (P = 0.001, hazard ratio 1.360, 95% confidence interval 1.138-1.625). The survival impact stemmed from SMARCA2-attenuated GCs in stage III and non-EBV/MSI diffuse/mixed subtypes (P = 0.019 and < 0.001, respectively). ARID1A-lost/heterogeneous GCs were more aggressive in the EBV genotype (P = 0.016). SMARCB1 or SMARCA4 loss was not restricted to rhabdoid/undifferentiated carcinoma. In the TCGA dataset, 223 of 434 GCs (52%) harbored deleterious SWI/SNF mutations, including ARID1A (27%), SMARCA2 (9%), ARID2 (9%), ARID1B (8%), PBRM1 (7%), and SMARCA4 (7%). SWI/SNF-mutated GCs displayed a favorable outcome owing to the high percentage with the MSI genotype. In conclusion, SWI/SNF-altered GCs are common and the clinicopathological significance is related to the genotype.

SUBMITTER: Huang SC 

PROVIDER: S-EPMC7822341 | BioStudies | 2021-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6175882 | BioStudies
2020-01-01 | S-EPMC7699259 | BioStudies
2017-01-01 | S-EPMC5699030 | BioStudies
2018-01-01 | S-EPMC6085491 | BioStudies
2013-07-20 | E-GEOD-40384 | ArrayExpress
2012-01-01 | S-EPMC3277150 | BioStudies
2017-01-01 | S-EPMC5760285 | BioStudies
2008-01-01 | S-EPMC2639326 | BioStudies
2016-01-01 | S-EPMC4832362 | BioStudies
2018-01-01 | S-EPMC5794756 | BioStudies